Actionable insights into your child’s health

We want our clients to feel secure about their family’s future health long after the birth of their child. That’s why we’ve partnered with Sema4 to bring you ReadyGen — an at-home pediatric genetic test that can unlock important details about your child’s health.

ReadyGen delivers personalized information on many conditions that can’t be detected by standard prenatal tests or state newborn screenings.*

Two tests for the price of one

ReadyGen pediatric screening

This test uses advanced DNA sequencing technology** to provide early detection of 200+ conditions.

All detected conditions can be managed with diet, medication, or other therapies (including 20+ addressable with newborn stem cells).

  • Beta thalassemia
  • Congenital amegakaryoctic thrombocytopenia
  • Dyskeratosis congenita
  • Fanconi anemia
  • Sickle Cell Disease
  • Wilms Tumor
  • Adenosine deaminase deficiency
  • Congenital neutropenia
  • Chronic granulomatous disease
  • Omenn syndrome
  • Gaucher disease
  • Hunter syndrome (MPS-II)
  • Hurler syndrome (MPS-IH)
  • Krabbe Disease
  • Mannosidosis
  • Maroteaux-Lamuy Syndrome (MPS-VI)
  • Morquio Syndrome (MPS-IV)
  • Mucolipidosis II (I-cell Disease)
  • Neuronal Ceroid Lipofuscinosis (Batten Disease)
  • Niemann-Pick Syndrome
  • Sanfilippo Syndrome (MPS-III)
  • Scheie Syndrome (MPS-IS)
  • Tay Sachs Disease
  • X-Linked Adrenoleukodystrophy

ReadyGen pharmacogenomic testing

These insights are provided to your child’s doctor to help recommend personalized medications in the future.

Analyzes your child’s response or sensitivity to 40+ medications

  • Celecoxib (CYP2C9)
  • Codeine (CYP2D6)
  • Hydrocodone (CYP2D6)
  • Oxycodone (CYP2D6)
  • Tramadol (CYP2D6)
  • Aminoglycosides (MT-RNR1)
  • Warfarin (CYP2C9, VKORC1)
  • Fosphenytoin (CYP2C9)
  • Phenytoin (CYP2C9)
  • Ondansetron (CYP2D6)
  • Voriconazole (CYP2C19)
  • Amitriptyline (CYP2D6, CYP2C19)
  • Citalopram (CYP2C19)
  • Clomipramine (CYP2D6, CYP2C19)
  • Desipramine (CYP2D6)
  • Doxepin (CYP2D6, CYP2C19)
  • Escitalopram (CYP2C19)
  • Fluoxetine (CYP2D6)
  • Fluvoxamine (CYP2D6)
  • Imipramine (CYP2D6)
  • Nortriptyline (CYP2D6)
  • Paroxetine (CYP2D6)
  • Sertraline (CYP2C19)
  • Trimipramine (CYP2D6, CYP2C19)
  • Simvastatin (SLCO1B1)
  • Capecitabine (DPYD)
  • Fluorouracil (DPYD)
  • Mercaptopurine (TPMT)
  • Thioguanine (TPMT)
  • Clopidogrel (CYP2C19)
  • Aripiprazole (CYP2D6)
  • Iloperidone (CYP2D6)
  • Pimozide (CYP2D6)
  • Atazanavir (UGT1A1)
  • Azathioprine (TPMT)
  • Tacrolimus (CYP3A5)
  • Eliglustat (CYP2D6)
  • Atomoxetine (CYP2D6)

Empowering parents with CBR’s Family Protection Package

ReadyGen helps you stay ahead of your new arrival’s health.

New families

Our Family Protection Package includes cord blood and cord tissue preservation along with both ReadyGen pediatric genetic screening tests.

Returning families

For our existing CBR parents, please call 888.932.6568 to learn more about ReadyGen.

*Worldwide, approximately 1 in 27 children screen positive for a genetic condition on the ReadyGen panel. If your child screens positive, a genetic counselor will contact you to discuss the results of the test and help you navigate next steps. The chance of a positive result varies depending on ethnicity.

**All of the genes have a well-established relationship with disease and meet eligibility criteria as set by ClinGen guidelines ( PMID: 28552198).

Evidence supporting associations between variants and drug response is obtained from a combination of sources, including: FDA drug labeling, guidelines written by a consortium of international experts (such as CPIC), and peer-reviewed research literature.

Have more questions?

Our Newborn Stem Cell Educators would love to help!

Chat now